Lithium and Valproate Levels Do Not Correlate with Ketamine's Antidepressant Efficacy in Treatment-Resistant Bipolar Depression
Ketamine and lithium both inhibit glycogen synthase kinase 3. In addition, lithium and ketamine have synergistic antidepressant-like effects at individually subeffective doses in rodents. We hypothesized that ketamine's antidepressant effects would be improved by therapeutic doses of lithium ve...
Description complète
Détails bibliographiques
Publié dans: | Neural plasticity. - 1998. - 2015(2015) vom: 07., Seite 858251
|
Auteur principal: |
Xu, Annie J
(Auteur) |
Autres auteurs: |
Niciu, Mark J,
Lundin, Nancy B,
Luckenbaugh, David A,
Ionescu, Dawn F,
Richards, Erica M,
Vande Voort, Jennifer L,
Ballard, Elizabeth D,
Brutsche, Nancy E,
Machado-Vieira, Rodrigo,
Zarate, Carlos A Jr |
Format: | Article en ligne
|
Langue: | English |
Publié: |
2015
|
Accès à la collection: | Neural plasticity
|
Sujets: | Journal Article
Randomized Controlled Trial
Research Support, N.I.H., Extramural
Research Support, N.I.H., Intramural
Antidepressive Agents
Valproic Acid
614OI1Z5WI
Ketamine
690G0D6V8H
Lithium
9FN79X2M3F |